Actively Recruiting
Adapting the FACETS Fatigue Management Program to Sickle Cell Disease
Led by Versailles Hospital · Updated on 2025-08-19
24
Participants Needed
2
Research Sites
N/A
Total Duration
On this page
Sponsors
V
Versailles Hospital
Lead Sponsor
U
University Hospital, Grenoble
Collaborating Sponsor
AI-Summary
What this Trial Is About
This research aims to adapt a fatigue management program called the FACETS program, which combines cognitive-behavioral therapy and energy conservation techniques, specifically for adult patients living with sickle cell disease. The study focuses on evaluating the feasibility of this adapted program, named Drépa-FACETS, for managing fatigue symptoms in this population. Participants will take part in the Drépa-FACETS program designed for sickle cell disease. The program includes sessions and home exercises tailored to help manage fatigue. The study will monitor participants from enrollment through the end of the protocol visits over a 10-week period. During the study, participants will complete assessments and questionnaires to measure fatigue and their ability to follow the program. The research team will evaluate how well the program works for adults with sickle cell disease by tracking adherence and outcomes related to fatigue management over the course of the study.
CONDITIONS
Brief Title
Adapting the FACETS Program to Sickle Cell Disease
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Participant having freely given his oral agreement.
- Participant with a major sickle cell syndrome, regardless of genotype (e.g. SS, SC, Sbeta).
- Participant with a sufficient command of spoken and written French to take the assessments, complete the questionnaires, follow the program sessions and carry out the home exercises.
You will not qualify if you...
- Participant with one or more severe psychiatric pathologies (e.g. severe depression, psychosis) that could interfere with the conduct of the study.
- Participants with another chronic pathology causing fatigue.
- Participants in vaso-occlusive crisis (VOC) or hospitalization.
- Participant under legal protection (guardianship, curatorship, safeguard of justice, deprived of liberty).
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 10 weeks
Participants take part in the Drépa-FACETS Program for Sickle Cell Disease, which includes program sessions and home exercises to manage fatigue.
Visits throughout the 10-week program as scheduled by the study team
Trial Site Locations
Total: 2 locations
1
CHU Grenoble Alpes
Grenoble, France, 38000
Actively Recruiting
2
Hospital Versailles
Le Chesnay, France, 78150
Completed
Research Team
M
Michalina DANNOUNE
D
Damien OUDIN-DOGLIONI, PhD
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
PREVENTION
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here